Chimerix to Speak Today at The White House Cancer Moonshot Forum
DURHAM, N.C., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX), a biopharmaceutical company whose mission it is to develop...
DURHAM, N.C., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX), a biopharmaceutical company whose mission it is to develop...
BEIJING, Jan. 13, 2025 /PRNewswire/ -- China Liberal Education Holdings Limited ("China Liberal" or the "Company") (NASDAQ: CLEU), a China-based company that...
BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA) – The Transplant Company™ – today reported preliminary, unaudited financial results for the fourth...
DENVER, Colo., 13 January, 2025 (247marketnews.com) – (NASDAQ:PDYN) are discussed in this article. Palladyne AI Corp. (PDYN) has demonstrated a...
Anticipates multiple clinical updates in the next 12-18 months, including further progress from two ongoing clinical programs and initiation of...
On track to report updated overall survival data for CAN-2409 from phase 2a clinical trials in pancreatic ductal adenocarcinoma (PDAC)...
AI-powered meeting summaries and smart video enhance collaboration and overall organizational productivity OR YEHUDA, Israel, Jan. 13, 2025 /PRNewswire/ --...
The first selective Fatty Acid Binding Protein 5 inhibitor safely administered to human subjects Initial safety and pharmacokinetic data expected...
NEW YORK, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Apollo Commercial Real Estate Finance, Inc. (the “Company” or “ARI”) (NYSE:ARI) today...
CLEARWATER, Fla, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Apyx Medical Corporation (NASDAQ:APYX) (the “Company”), the manufacturer of a proprietary helium...
THE WOODLANDS, TX, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical...
Achieves 35% year-over-year growth to 209,900 members on Jan. 1, showing how Medicare Advantage can be done rightAnnounces year-end 2025...
New Commercial Supply Contracts for Vafseo® (vadadustat) secured, bringing availability and dialysis organization coverage to nearly 100% of patients on...
DALLAS, Jan. 13, 2025 /PRNewswire/ -- Ashford Hospitality Trust, Inc. (NYSE: AHT) ("Ashford Trust" or the "Company") reported today that...
WEWAHITCHKA and PORT ST JOE, Fla., Jan. 13, 2025 (GLOBE NEWSWIRE) -- UAV Corp (OTC: UMAV), a leader in innovative...
Michel Forest to succeed David Wendling as Chief Technology OfficerAsit Tandon joins as Chief Network and Information Officer OTTAWA, Ontario,...
Continued Focus on Driving Advancement of TN-201 and TN-401 Gene Therapies for Cardiomyopathies Dosing Initiated in Cohort 2 of the MyPEAK™-1...
Versatile First Responder Communication Tools are Force Multipliers DENVER, Colo., Jan 13, 2025 (247marketnews.com)- As firefighters from around the world...
DENVER, Colo., 13 January, 2025 (247marketnews.com) – (NASDAQ:STIM) are discussed in this article. Neuronetics, Inc. has demonstrated significant momentum in...
DENVER, Colo., 13 January, 2025 (247marketnews.com) – (NASDAQ:ELEV) are discussed in this article. Elevation Oncology, Inc. is currently navigating a...
- Customer forecasts full ramp-up to reach $2M/year – KFAR SAVA, Israel, Jan. 13, 2025 /PRNewswire/ -- Silicom Ltd. (NASDAQ:...
JOHNSON CITY, Tenn., Jan. 13, 2025 /PRNewswire/ -- Crown Laboratories, Inc. ("Crown"), a privately held, global innovative leader in the skincare...
IRVINE, Calif. and CAMBRIDGE, Mass., Jan. 13, 2025 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight...
DENVER, Colo., 13 January, 2025 (247marketnews.com) – (NASDAQ:ELEV) are discussed in this article. Elevation Oncology, Inc. has recently garnered attention...
Pivotal data evaluating the safety and efficacy of the subretinal delivery of ABBV-RGX-314 in patients with wet age-related macular degeneration...
Montreal, Quebec--(Newsfile Corp. - January 13, 2025) - Quantum eMotion Corp. (TSXV: QNC) (OTCQB: QNCCF) (FSE: 34Q0) ("QeM" or the...
Niagara Falls, NY, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Positron Corporation ("Positron" or the "Company") (OTC: POSC), a leading molecular...
– PRGN-2012 has potential to be first FDA-approved therapeutic for treatment of RRP, a rare and devastating chronic disease – – ...
Creates the second largest publicly traded BDC by total assets NEW YORK, Jan. 13, 2025 /PRNewswire/ -- Blue Owl Capital...
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Jan. 13, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical...
BANNOCKBURN, Ill., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH),...
MINNEAPOLIS, Jan. 13, 2025 (GLOBE NEWSWIRE) -- OneMedNet Corporation (Nasdaq: ONMD) (“OneMedNet” or the “Company”), a global provider of clinical...
Creates the second largest publicly traded BDC by total assets NEW YORK, Jan. 13, 2025 /PRNewswire/ -- Blue Owl Capital...
MINNEAPOLIS, Jan. 13, 2025 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives...
Management believes uplisting has the potential to provide shareholders with improved liquidity Requires NRx Pharmaceuticals to meet certain listing requirements...
The approval was obtained from the Melz Municipal Committee in connection with the submission of Solterra’s statutory plan for the...
Disease awareness campaign encourages men to overcome their embarrassment and openly discuss Peyronie's disease (PD), taking charge of their health. Campaign...
BRAINTREE, Mass., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer of the innovative LIBERTY® Endovascular Robotic...
SALT LAKE CITY, Jan. 13, 2025 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN), a leading health and wellness company with...
Preliminary, unaudited revenue for the full year 2024 of approximately $174 million Presenting at the 43rd Annual J.P. Morgan Healthcare...